Monday, 26 September 2016

GW's cannabis-derived drug succeeds in third epilepsy study

(Reuters) - Britain's GW Pharmaceuticals Plc said its experimental cannabis-derived drug for a rare form of childhood epilepsy succeeded in a third late-stage U.S. study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)